Trial Profile
A Double-Blind, Randomized, Vehicle-Controlled, Six-Week Exploratory Multicenter Pilot Study of the Efficacy and Safety of Azelaic Acid (AzA) 15% Gel in the Topical Treatment of Mild to Moderate Seborrheic Dermatitis of the Face
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Azelaic acid (Primary)
- Indications Seborrhoeic dermatitis
- Focus Therapeutic Use
- Sponsors LEO Pharma
- 04 Dec 2013 New trial record